Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors

Clinical trial NCT05431582 · WITHDRAWN

Trial details

NCT number: NCT05431582
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Tumors Ovarian Cancer Breast Cancer Lung Cancer Pancreatic Cancer

Start date: 2022-12-14
Primary completion: 2022-12-14
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.